Harold Bernstein - President, R&D & CMO at Maze Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, R&D & CMO
Issuer Symbol
MAZE on Nasdaq
All Insider Reports
All Insider Reports

Harold Bernstein - trading volume in the past year for Maze Therapeutics, Inc.

Holdings reported by Harold Bernstein for Maze Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 0 $0 $51.02 10 Mar 2026 Direct
Stock Option (Right to Buy) 267,407 10 Mar 2026 Direct Common Stock
Restricted Stock Units 24,000 02 Mar 2026 Direct Common Stock

Transactions reported by Harold Bernstein for Maze Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.